• Issue

    The Prostate: Volume 84, Issue 5

    415-510
    April 2024
Previous Issue|Next Issue
Export Citation(s)Download PDF(s)

ISSUE INFORMATION

Free Access

Issue Information

  • Page: 415
  • First Published: 24 February 2024

REVIEW ARTICLES

Link between circadian rhythm and benign prostatic hyperplasia (BPH)/lower urinary tract symptoms (LUTS)

Dana Cavanaugh BSN, RN,  Alfonso Urbanucci PhD,  Nihal E. Mohamed PhD,  Ashutosh K. Tewari MBBS,  Mariana Figueiro PhD,  Natasha Kyprianou MBBS, PhD, 
  • Pages: 417-425
  • First Published: 09 January 2024

Diagnosis and management of neuroendocrine prostate cancer

Ivan de Kouchkovsky MD,  Emily Chan MD, PhD,  Charles Schloss MD,  Christian Poehlein MD,  Rahul Aggarwal MD, 
  • Pages: 426-440
  • First Published: 03 January 2024

ORIGINAL ARTICLES

Transcriptomic analysis of benign prostatic hyperplasia identifies critical pathways in prostatic overgrowth and 5-alpha reductase inhibitor resistance

Renjie Jin MD, PhD,  Connor M. Forbes MD,  Nicole L. Miller MD,  John Lafin PhD,  Douglas W. Strand PhD,  Thomas Case BS,  Justin M. Cates MD, PhD,  Qi Liu PhD,  Marisol Ramirez-Solano MS,  James L. Mohler MD,  Robert J. Matusik PhD, 
  • Pages: 441-459
  • First Published: 03 January 2024

Whole-exome sequencing of Nigerian benign prostatic hyperplasia reveals increased alterations in apoptotic pathways

Jason A. White PhD,  Ernest T. Kaninjing DrPH,  Kayode A. Adeniji MBChB,  Paul Jibrin MBChB,  John O. Obafunwa MD, FMCPath, FRCPath,  Chidiebere N. Ogo MBBS, MSc, FWACS,  Faruk Mohammed MSc,  Ademola Popoola MD, FWACS,  Omolara A. Fatiregun MBBS, FWACS,  Olabode P. Oluwole MBBS,  Roland J. Thorpe Jr. PhD,  Balasubramanyam Karanam PhD,  Isra Elhussin MBBS, MSc, PhD,  Stefan Ambs PhD, MPH,  Wei Tang PhD,  Melissa Davis PhD,  Paz Polak PhD,  Moray J. Campbell PhD,  Kathryn R. Brignole MSc,  Solomon O. Rotimi PhD,  Windy Dean-Colomb MD,  Folake T. Odedina PhD,  Clayton Yates PhD, 
  • Pages: 460-472
  • First Published: 08 January 2024

Variability of mpMRI diagnostic performance according to the upfront individual patient risk of having clinically significant prostate cancer

Francesco Pellegrino MD,  Armando Stabile MD,  Gabriele Sorce MD,  Elio Mazzone MD,  Donato Cannoletta MD,  Giuseppe Ottone Cirulli MD,  Leonardo Quarta MD,  Riccardo Leni MD,  Daniele Robesti MD,  Giorgio Brembilla MD,  Giorgio Gandaglia MD,  Francesco De Cobelli,  Francesco Montorsi MD,  Alberto Briganti MD, 
  • Pages: 473-478
  • First Published: 27 December 2023
Open Access

Prostate-specific membrane antigen (PSMA) glycoforms in prostate cancer patients seminal plasma

Stephen Mackay PhD,  Ian O. Oduor BSc,  Tanya C. Burch PhD,  Dean A. Troyer MD,  Oliver J. Semmes PhD,  Julius O. Nyalwidhe PhD, 
  • Pages: 479-490
  • First Published: 27 December 2023
Open Access

Distribution of neurovascular structures within the prostate gland and their relationship to complications after radical prostatectomy

Ghazi Alanazi PhD,  Najah Alsubaie PhD,  Ghulam Nabi PhD,  Thomas H. Gillingwater PhD,  Abduelmenem Alashkham PhD, 
  • Pages: 491-501
  • First Published: 03 January 2024

Fewer systematic prostate core biopsies in clinical stage T1c prostate cancer leads to biochemical recurrence after brachytherapy as monotherapy

Yu Ozawa MD,  Sunao Nohara MD,  Ken Nakamura MD,  Seiya Hattori MD, PhD,  Yasuto Yagi MD,  Toru Nishiyama MD,  Atsunori Yorozu MD, PhD,  Tetsuo Monma MD, PhD,  Shiro Saito MD, PhD, 
  • Pages: 502-510
  • First Published: 03 January 2024